Mydecine Innovations Group M&A Summary
Mydecine Innovations Group has acquired 4 companies, including 4 in the last 5 years. It has also divested 1 asset.
Mydecine Innovations Group’s largest acquisition to date was in 2020, when it acquired Mindleap Health for $3M. It’s largest disclosed sale occurred in 2022, when it sold Mindleap Health to PanGenomic Health for $3M. Mydecine Innovations Group has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include consumer products (50%) and healthcare services (25%).
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity4
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 1